Search Results - Adamu Uzairu

Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor by Shola Elijah Adeniji, Sani Uba, Adamu Uzairu

Connect to this object online.

Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors by Muhammad Tukur Ibrahim, Adamu Uzairu, Sani Uba, Gideon Adamu Shallangwa

Connect to this object online.

QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent by Abduljelil Ajala, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi

Connect to this object online.

In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions by Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba

Connect to this object online.

Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents by Sabitu Babatunde Olasupo, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba

Connect to this object online.

Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions by Stephen Ejeh, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi

Connect to this object online.

In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins by Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu, Ibrahim Abdulkadir

Connect to this object online.

Molecular Docking Screening and Pharmacokinetic Studies of Some Boron-Pleuromutilin Analogues against Possible Targets of Wolbachia pipientis by Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu, Ibrahim Abdulkadir

Connect to this object online.

Molecular Docking Investigation, Pharmacokinetic Analysis, and Molecular Dynamic Simulation of Some Benzoxaborole-Benzimidazole Hybrids: An Approach to Identifying Superior Onchoce... by Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu, Ibrahim Abdulkadir

Connect to this object online.

Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach by Muhammad Tukur Ibrahim, Adamu Uzairu, Sani Uba, Gideon Adamu Shallangwa

Connect to this object online.

2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease by Abduljelil Ajala, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi

Connect to this object online.

Virtual screening, pharmacokinetics, and molecular dynamics simulations studies to identify potent approved drugs for Chlamydia trachomatis treatment by Emmanuel Israel Edache, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza

Connect to this object online.

2D-QSAR, Docking, Molecular dynamics simulations with the MM/GBSA approaches against Grave's disease and PTPN22 by Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa

Connect to this object online.

Pharmacokinetic predictions and docking studies of substituted aryl amine-based triazolopyrimidine designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHOD... by Zakari Ya'u Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen Eyije Abechi

Connect to this object online.

Potential anti-colon cancer agents: Molecular modelling, docking, pharmacokinetics studies and molecular dynamic simulations by Auwal Salisu Isa, Adamu Uzairu, Umar Mele Umar, Muhammad Tukur Ibrahim, Abdullahi Bello Umar, Iqrar Ahmad

Connect to this object online.